FIGURE

Fig. 5

ID

ZDB-FIG-241126-14

Publication

Yu et al., 2024 - Aspirin reduces Ponatinib-induced cardiovascular toxic phenotypes and death in zebrafish

Other Figures

All Figure Page

Back to All Figure Page

Fig. 5

The effects of anti-thrombotic drugs on Ponatinib-induced thrombosis in zebrafish larvae. (A) 1 dpf Tg (gata1: dsRed) transgenic zebrafish larvae were treated with 0.1 % DMSO or 10 ?M Ponatinib or co-treated with 10 ?M Ponatinib and 25 ?g/ml Aspirin or 25 ?g/ml Clopidogrel or 25 ?g/ml Dipyridamole for 3 days. The represented images of the blood flow in different groups. (B) The rate of blood flow stops in 15 fish/group batches. Data are represented as mean � SEM. ###P < 0.005 vs. control group; **P < 0.01 and ***P < 0.005 vs. Ponatinib group. (C) The represented images and (D) quantification of thrombus formation in different groups detected by the o-dianisidine staining (n=8). Data are represented as mean � SEM. ###P < 0.005 versus control group; ***P < 0.005 vs. Ponatinib group. (E) The erythrocytes (red colour) in heart was detected by the o-dianisidine staining. The area in the red dashed line square was measured by Image J (n=8). Data are represented as mean � SEM. ###P < 0.005 versus control group; ***P < 0.005 vs. Ponatinib group.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Fish:	AB
Conditions:	chemical treatment by environment: ponatinib chemical treatment by environment: ponatinib chemical treatment by environment: ponatinib chemical treatment by environment: ponatinib
Observed In:	heart nucleate erythrocyte parachordal vessel blood circulation parachordal vessel thrombocyte activation
Stage:	Day 4

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biomed. Pharmacother.